We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Results: 2

1.
Figure 1

Figure 1. From: Standard Operating Procedure for Prospective Individualised Dosimetry for [131]I-rituximab Radioimmunotherapy of Non-Hodgkin's Lymphoma.

Total whole body residence time estimation

Phillipe J. Calais, et al. World J Nucl Med. 2012 Sep-Dec;11(3):110-116.
2.
Figure 2

Figure 2. From: Standard Operating Procedure for Prospective Individualised Dosimetry for [131]I-rituximab Radioimmunotherapy of Non-Hodgkin's Lymphoma.

Total whole body residence time calculation

Phillipe J. Calais, et al. World J Nucl Med. 2012 Sep-Dec;11(3):110-116.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk